Transplant patients have unique dermatological needs, including:
- infective skin problems
- numerous precancerous lesions (actinic keratoses, Bowen's disease)
- skin cancers.
Immunosuppressant drugs used by transplant patients increase the risk of skin cancers. Squamous cell carcinomas (SCC) are the most common post-transplant malignancy.
Their problems are often multiple, complex and time consuming.
The Skin Health Institute's Transplant Clinic is set up to manage the skin of patients who have had organ transplants.
Associate Professor Alvin Chong
Dr Aaron Robinson
Dr Sarah Brennand
Dr Michelle Goh
Dr Rebecca Dunn
Dr Jane Li
Download the brochure
skin cancer database
Patients are invited to take part in this research project, Skin Health Institute Skin Cancer Database. The research project is aiming to collect information about people who are immunosuppressed, have received an organ transplant, and people who are at high risk of developing skin cancer for other reasons.
More information can be found in the Participant Information Sheet/Consent Form. If a patient would like to participate, we encourage them to complete the form prior to their appointment.
Participation in this research is voluntary, and patients will receive the best possible care whether or not they take part.
Patient Information Sheet